| Product Code: ETC10070177 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Vietnam Cell And Gene Therapy Clinical Trial Services Market Overview |
3.1 Vietnam Country Macro Economic Indicators |
3.2 Vietnam Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume, 2021 & 2031F |
3.3 Vietnam Cell And Gene Therapy Clinical Trial Services Market - Industry Life Cycle |
3.4 Vietnam Cell And Gene Therapy Clinical Trial Services Market - Porter's Five Forces |
3.5 Vietnam Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume Share, By Service, 2021 & 2031F |
3.6 Vietnam Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume Share, By Phase, 2021 & 2031F |
3.7 Vietnam Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume Share, By Therapeutic Areas, 2021 & 2031F |
3.8 Vietnam Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume Share, By Therapy Type, 2021 & 2031F |
4 Vietnam Cell And Gene Therapy Clinical Trial Services Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of genetic disorders and chronic diseases in Vietnam |
4.2.3 Favorable government regulations and policies supporting cell and gene therapy clinical trials |
4.3 Market Restraints |
4.3.1 Limited awareness and understanding of cell and gene therapy among healthcare professionals and patients in Vietnam |
4.3.2 High costs associated with cell and gene therapy clinical trials |
4.3.3 Lack of skilled workforce and expertise in conducting clinical trials for cell and gene therapy in Vietnam |
5 Vietnam Cell And Gene Therapy Clinical Trial Services Market Trends |
6 Vietnam Cell And Gene Therapy Clinical Trial Services Market, By Types |
6.1 Vietnam Cell And Gene Therapy Clinical Trial Services Market, By Service |
6.1.1 Overview and Analysis |
6.1.2 Vietnam Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume, By Service, 2021- 2031F |
6.1.3 Vietnam Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume, By Site Identification, 2021- 2031F |
6.1.4 Vietnam Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume, By Patient Recruitment, 2021- 2031F |
6.1.5 Vietnam Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume, By Laboratory Services, 2021- 2031F |
6.1.6 Vietnam Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume, By Regulatory Services, 2021- 2031F |
6.1.7 Vietnam Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume, By Supply and Logistic Services, 2021- 2031F |
6.1.8 Vietnam Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Vietnam Cell And Gene Therapy Clinical Trial Services Market, By Phase |
6.2.1 Overview and Analysis |
6.2.2 Vietnam Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume, By Phase I, 2021- 2031F |
6.2.3 Vietnam Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume, By Phase II, 2021- 2031F |
6.2.4 Vietnam Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume, By Phase III, 2021- 2031F |
6.2.5 Vietnam Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume, By Phase IV, 2021- 2031F |
6.3 Vietnam Cell And Gene Therapy Clinical Trial Services Market, By Therapeutic Areas |
6.3.1 Overview and Analysis |
6.3.2 Vietnam Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume, By Oncology, 2021- 2031F |
6.3.3 Vietnam Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume, By Central Nervous System (CNS) Disorders, 2021- 2031F |
6.3.4 Vietnam Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume, By Cardiovascular Diseases, 2021- 2031F |
6.3.5 Vietnam Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume, By Infectious Diseases, 2021- 2031F |
6.3.6 Vietnam Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume, By Musculoskeletal, 2021- 2031F |
6.3.7 Vietnam Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Vietnam Cell And Gene Therapy Clinical Trial Services Market, By Therapy Type |
6.4.1 Overview and Analysis |
6.4.2 Vietnam Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume, By Gene Therapy, 2021- 2031F |
6.4.3 Vietnam Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume, By Gene-modified Cell Therapy, 2021- 2031F |
6.4.4 Vietnam Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume, By Cell Therapy, 2021- 2031F |
6.4.5 Vietnam Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume, By Others, 2021- 2031F |
7 Vietnam Cell And Gene Therapy Clinical Trial Services Market Import-Export Trade Statistics |
7.1 Vietnam Cell And Gene Therapy Clinical Trial Services Market Export to Major Countries |
7.2 Vietnam Cell And Gene Therapy Clinical Trial Services Market Imports from Major Countries |
8 Vietnam Cell And Gene Therapy Clinical Trial Services Market Key Performance Indicators |
8.1 Patient recruitment rate for cell and gene therapy clinical trials |
8.2 Number of collaborations between local research institutions and international biotech companies for conducting clinical trials |
8.3 Success rate in obtaining regulatory approvals for cell and gene therapy clinical trials |
9 Vietnam Cell And Gene Therapy Clinical Trial Services Market - Opportunity Assessment |
9.1 Vietnam Cell And Gene Therapy Clinical Trial Services Market Opportunity Assessment, By Service, 2021 & 2031F |
9.2 Vietnam Cell And Gene Therapy Clinical Trial Services Market Opportunity Assessment, By Phase, 2021 & 2031F |
9.3 Vietnam Cell And Gene Therapy Clinical Trial Services Market Opportunity Assessment, By Therapeutic Areas, 2021 & 2031F |
9.4 Vietnam Cell And Gene Therapy Clinical Trial Services Market Opportunity Assessment, By Therapy Type, 2021 & 2031F |
10 Vietnam Cell And Gene Therapy Clinical Trial Services Market - Competitive Landscape |
10.1 Vietnam Cell And Gene Therapy Clinical Trial Services Market Revenue Share, By Companies, 2024 |
10.2 Vietnam Cell And Gene Therapy Clinical Trial Services Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here